OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
19
Results
Show all
Save search
Copy query
Show results for
Unknown
(19)
Publication Date
Release Date
2024
(5)
2020
(4)
2025
(3)
2022
(2)
2021
(2)
2026
(1)
2016
(1)
2014
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer susceptibility.
Not available
S-EPMC4145786
|
biostudies-literature
Cite
Exploring the Causal Link Between Plasma Lipidome and Trigeminal Neuralgia Using Bidirectional Mendelian Randomization.
Not available
S-EPMC12316502
|
biostudies-literature
Cite
Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients.
Not available
S-EPMC8646019
|
biostudies-literature
Cite
Extracting the femtometer structure of strange baryons using the vacuum polarization effect.
Not available
S-EPMC11470094
|
biostudies-literature
Cite
Robust estimation of bacterial cell count from optical density.
Not available
S-EPMC7499192
|
biostudies-literature
Cite
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Not available
S-EPMC4835977
|
biostudies-literature
Cite
Initial Invasive or Conservative Strategy for Stable Coronary Disease.
Not available
S-EPMC7263833
|
biostudies-literature
Cite
Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease.
Not available
S-EPMC7261489
|
biostudies-literature
Cite
Evaluating the Appropriate Use Criteria for Coronary Revascularization in Stable Ischemic Heart Disease Using Randomized Data From the ISCHEMIA Trial.
Not available
S-EPMC11919559
|
biostudies-literature
Cite
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial.
Not available
S-EPMC11187765
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets